Has Claudia Pierson received payments from drug or device companies?

Yes. Drug and device makers reported $2,815 in general payments to Claudia Pierson across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Claudia Pierson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Claudia Pierson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Claudia Pierson

Internal Medicine · Weslaco, TXNPI 1215158167

Payments from drug & device makers

$2,815in general payments, 2019–2025

Across 129 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$448
Lilly USA, LLC$373
Johnson & Johnson$320
Novo Nordisk$264
Medtronic$199
GSK$173
plus $1K from 19 others

What the payments were for

Food & beverage$2,79699%
Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	3	$448
Lilly USA, LLC	15	$373
Johnson & Johnson	15	$320
Novo Nordisk	17	$264
Medtronic	6	$199
GSK	9	$173
AstraZeneca	11	$157
Merck	8	$149
Pfizer	7	$122
Astellas Pharma US Inc	6	$94
Sanofi-aventis U.S. LLC	6	$93
Boehringer Ingelheim	4	$69
Amgen	3	$44
AbbVie(2 entities)	2	$41
Bayer	2	$40
Esperion Therapeutics, Inc.	2	$36
Novartis	2	$28
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$28
Amarin Pharma, Inc.	2	$27
Optinose US, Inc.	2	$26
Radius Health, Inc.	1	$23
Pelvital USA, Inc.	1	$18
Kowa Pharmaceuticals America, Inc.	1	$18
Paratek Pharmaceuticals, Inc.	1	$13
Si-bone, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,815 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	25	$30,962
EliquisApixaban	13	$12,204
Omeprazole	21	$438
Rosuvastatin Calcium	26	$418
Levothyroxine Sodium	29	$321
Montelukast Sodium	14	$315
Atorvastatin Calcium	31	$228
Metoprolol Succinate	14	$212
Pravastatin Sodium	11	$192
Simvastatin	18	$185
Amlodipine Besylate	25	$175
Metformin Hcl	15	$162
Lisinopril	27	$155
Pantoprazole Sodium	12	$137
Levocetirizine Dihydrochloride	12	$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Boehringer IngelheimJardiance	$69	$30,96225 claims
PfizerEliquis	$122	$12,20413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,675 internal medicine providers in Texas.

Other internal medicine in Weslaco

Jan BurgerHouston$47.3M
Nitin JainHouston$33.2M
Muhammad IrfanTomball$30.6M
Aung NaingHouston$30.6M
Robert BassSan Antonio$25.6M
Preetesh JainHouston$19.5M
Paolo StratiHouston$19.2M
Hernan SalazarSan Antonio$18.5M
Nicholas ShortHouston$17.6M
Salma SaigerMesquite$16.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →